"MidHudson Regional Hospital, located in Poughkeepsie, NY, is a 243-bed hospital and the area's first Level II Trauma Center. The facility is home to an Emergency Department and provides care for the Mid Hudson Valley. Services include behavioral health, cancer care, diabetes care, ear, nose & throat, heart & vascular, neurosciences, orthopaedics, radiology & imaging, rehabilitation med, sleep center, surgery, and wound care. Plus licensed home care, early ed, hearing, balance & speech, and occupational health. MidHudson Regional Hospital is a member of the Westchester Medical Center Health Network, a 1,700-bed healthcare system headquartered in Valhalla, New York, with 10 hospitals on eight campuses spanning 6,200 square miles."

During the past decade, MidHudson Regional Hospital of Westchester Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MidHudson Regional Hospital of Westchester Medical Center" #1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "MidHudson Regional Hospital of Westchester Medical Center" are "Breast Ductal Carcinoma In Situ" (2 trials), "HER2/Neu Positive" (2 trials), "Recurrent Melanoma" (2 trials), "Stage IA Breast Cancer AJCC v7" (2 trials) and "Stage IB Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "MidHudson Regional Hospital of Westchester Medical Center" in a lesser frequency.

Most popular intervention types in "MidHudson Regional Hospital of Westchester Medical Center" are "Other" (8 trials), "Drug" (6 trials), "Biological" (5 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (4 trials), "Paclitaxel" (3 trials), "Trastuzumab" (3 trials) and "Anastrozole" (2 trials). Other intervention names were less common.

The vast majority of trials in "MidHudson Regional Hospital of Westchester Medical Center" are 5 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "MidHudson Regional Hospital of Westchester Medical Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MidHudson Regional Hospital of Westchester Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MidHudson Regional Hospital of Westchester Medical Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".